Skip to content

Role of Dhanadanayanadi Kashay in neuropathy.

Randomised controlled clinical trial to evaluate efficacy of Dhanadanayanadi Kashay in management of Distal Symmetrical Polyneuropathy in chronic type 2 Diabetes Mellitus in comparison with Pregabalin. - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087823
Enrollment
52
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G628- Other specified polyneuropathies

Interventions

None listed

Sponsors

Dr Neha Dipak More
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group within 40-70years. 2.Patients irrespective of gender will be included and who are willing to take medicine. 3.Patients haning TCNS score more than or equal to 6 and less than or equal to 11. 4.Patients having HBA1C upto 10%. 5.Type 2 DM patients presenting with any of the signs like pain,numbness, tingling sensation,burning sensation.

Exclusion criteria

Exclusion criteria: 1)Patients having type1 DM. 2)Causes of neuropathy other than diabetes mellitus like alcoholic neuropathy, neuropathy due to vit.B12 difficiency,due to thyroidism etc. 3)Patients with K/C/0 Tuberculosis,AIDS ,Mlignancies,Leprosy 4)Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of Dhanadanayanadi Kashay in comparison with Pregabalin in Distal Symmetrical Polyneuropathy.Timepoint: 3 Months

Secondary

MeasureTime frame
To assess efficacy of Dhanadanayanadi Kashay in management of distal symmetrical polyneuropathy in the parameters of Toronto Clinical Neuropathy ScoreTimepoint: 3 months;To study probable mode of action of drug of study.Timepoint: 3 months

Countries

India

Contacts

Public ContactDrNeha Dipak More

Dr.G.D.Pol Foundations Ayurvedic Medical College, Sector 4 Kharghar, Navi Mumbai

vdaparnasathe@gmail.com9819216230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026